What question did this study set out to answer?

The study aims to investigate the effects of SSRI use during pregnancy on maternal and neonatal health outcomes.

February 9, 2026Open Access

SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn

Key Points

The study aims to investigate the effects of SSRI use during pregnancy on maternal and neonatal health outcomes.
Analyzed data from a nationwide birth cohort
Assessed neonatal health outcomes in relation to maternal SSRI use
Examined risks for gestational diabetes and preterm birth
Increased symptoms of delayed neonatal adaptation linked to SSRI use
Potential reduction in the risk of preterm birth observed
Heightened risk of gestational diabetes identified, suggesting need for further research

Abstract

SSRI use during pregnancy affects neonatal health beyond maternal depression by increasing symptoms related to delayed neonatal adaptation, although it may reduce the risk of preterm birth. The observed increase in the risk of gestational diabetes warrants further study. VIDEO ABSTRACT.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper